Top Institutions in Ophthalmology and Rare Genetic Disorders
Institutions were ranked based on their known expertise in rare ocular diseases, genetic and metabolic disorders, and leadership in translational research and clinical trials involving plasminogen deficiency and related treatments.
-
#1
National Eye Institute (NEI), National Institutes of Health
Bethesda, MD
NEI leads in research on rare ocular diseases including ligneous conjunctivitis, with extensive clinical trials and genetic studies on plasminogen deficiency. Their integration within NIH facilitates cutting-edge translational research and access to novel therapies like RYPLAZIM.
-
#2
Mayo Clinic
Rochester, MN
Mayo Clinic has a multidisciplinary approach combining ophthalmology and genetics to diagnose and treat rare disorders like PLGD-1. Their expertise in complex systemic diseases and access to advanced genetic testing supports comprehensive patient care.
-
#3
Johns Hopkins University School of Medicine
Baltimore, MD
Johns Hopkins is recognized for its research and clinical expertise in rare genetic diseases affecting the eye and systemic organs. Their ophthalmology and genetic medicine departments collaborate on innovative diagnostics and treatments for conditions like PLGD-1.
-
#4
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Massachusetts Eye and Ear is a leader in ophthalmic care and research, including rare conjunctival disorders. Their collaboration with Harvard Medical School enhances their capabilities in genetic research and novel therapeutic approaches for PLGD-1.